Fundraising FoxAdvanced Chemotherapy Technologies
Raleigh, US · Delaware corporation · 1 known investors
Find your way into Advanced Chemotherapy Technologies
Sign up to see every warm intro you have to Advanced Chemotherapy Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Advanced Chemotherapy Technologies team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JJ
Jen Jen YehNamed on SEC filing
AS
Anthony S. VoiersNamed on SEC filing
JD
Joseph DeSimoneNamed on SEC filing
Investors · 1
Khosla VenturesreportedMenlo Park · $100K – $20M
How we know: funding news · businesswire.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 2 rounds · 2020–2024
▶$950KraisedMar 2024 · 2 investors · BiotechnologyRule 506(b)
▶$950KraisedMar 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nessan BerminghamDirector
- Jen Jen YehDirector
- Joseph DeSimoneDirector
- Michael AldridgeExecutive Officer, Director
- Offering amount
- $950K
- Amount sold
- $950K
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedNov 2020 · 1 investors · BiotechnologyRule 506(b)
▶$5.5MraisedNov 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jen Jen YehDirector
- Anthony S. VoiersExecutive Officer, Director, Promoter
- Joseph DeSimoneDirector
- Offering amount
- $14.1M
- Amount sold
- $5.5M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Advanced Chemotherapy Technologies's investors?
- Advanced Chemotherapy Technologies's investors include Khosla Ventures.
- How much funding has Advanced Chemotherapy Technologies raised?
- Advanced Chemotherapy Technologies has disclosed $6.4M raised across 2 rounds.
- Where is Advanced Chemotherapy Technologies headquartered?
- Advanced Chemotherapy Technologies is headquartered in Raleigh, US.